马普替林
马普替林用途
该品为新型的抗忧郁药。用于治疗千种类型的忧郁症,对疾病或精神因素引起的焦虑、忧郁状态患者有效,还可用于伴有忧郁、激动行为障碍的儿童及夜尿者。本品疗效好,副作用小,还具有安定作用。小鼠口服LD50为480mg/kg,大鼠为1250mg/kg。
马普替林名称
[ CAS 号 ]:
10262-69-8
[ 中文名 ]:
马普替林
[ 英文名 ]:
maprotiline
[中文别名 ]:
[英文别名 ]:
- Deprilept
- Dibencycladine
- N-methyl-9,10-ethanoanthracene-9(10H)-propanamine
- Maprotilina
- Maprotylina [Polish]
- Maprotilinum
- MFCD00661057
- Maprotilin
- Maprotilinum [INN-Latin]
- EINECS 233-599-4
马普替林生物活性
[ 描述 ]:
[ 相关类别 ]:
[体外研究]
[体内研究]
[参考文献]
马普替林物理化学性质
[ 密度 ]:
1.08 g/cm3
[ 沸点 ]:
399.6ºC at 760 mmHg
[ 分子式 ]:
C20H23N
[ 分子量 ]:
277.40300
[ 闪点 ]:
187.7ºC
[ 精确质量 ]:
277.18300
[ PSA ]:
12.03000
[ LogP ]:
4.60230
[ 蒸汽压 ]:
1.35E-06mmHg at 25°C
[ 折射率 ]:
1.599
[ 储存条件 ]:
室温,密闭,干燥
马普替林毒性和生态
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- KJ4552000
- CHEMICAL NAME :
- 9,10-Ethanoanthracene-9(10H)-propylamine, N-methyl-
- CAS REGISTRY NUMBER :
- 10262-69-8
- LAST UPDATED :
- 199612
- DATA ITEMS CITED :
- 9
- MOLECULAR FORMULA :
- C20-H23-N
- MOLECULAR WEIGHT :
- 277.44
- WISWESSER LINE NOTATION :
- L6 H666/GP 2AF P&&TTJ O3M1
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - child
- DOSE/DURATION :
- 26 mg/kg
- TOXIC EFFECTS :
- Behavioral - somnolence (general depressed activity) Behavioral - coma Vascular - BP elevation not characterized in autonomic section
- REFERENCE :
- BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 2,260,1977
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 760 mg/kg
- TOXIC EFFECTS :
- Behavioral - muscle weakness Behavioral - ataxia Behavioral - muscle contraction or spasticity
- REFERENCE :
- HEPHD2 Handbook of Experimental Pharmacology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.50- 1978- Volume(issue)/page/year: 55,527,1980
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 105 mg/kg
- TOXIC EFFECTS :
- Behavioral - somnolence (general depressed activity) Behavioral - muscle weakness Lungs, Thorax, or Respiration - dyspnea
- REFERENCE :
- APPHAX Acta Poloniae Pharmaceutica. For English translation, see APPFAR. (Ars Polona, POB 1001, 00-680 Warsaw 1, Poland) V.1- 1937- Volume(issue)/page/year: 40,235,1983
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 38 mg/kg
- TOXIC EFFECTS :
- Behavioral - muscle weakness Behavioral - ataxia Behavioral - muscle contraction or spasticity
- REFERENCE :
- HEPHD2 Handbook of Experimental Pharmacology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.50- 1978- Volume(issue)/page/year: 55,527,1980
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 660 mg/kg
- TOXIC EFFECTS :
- Behavioral - muscle weakness Behavioral - ataxia Behavioral - muscle contraction or spasticity
- REFERENCE :
- HEPHD2 Handbook of Experimental Pharmacology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.50- 1978- Volume(issue)/page/year: 55,527,1980
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 140 mg/kg
- TOXIC EFFECTS :
- Behavioral - altered sleep time (including change in righting reflex) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea
- REFERENCE :
- APPHAX Acta Poloniae Pharmaceutica. For English translation, see APPFAR. (Ars Polona, POB 1001, 00-680 Warsaw 1, Poland) V.1- 1937- Volume(issue)/page/year: 40,235,1983
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 31 mg/kg
- TOXIC EFFECTS :
- Behavioral - muscle weakness Behavioral - ataxia Behavioral - muscle contraction or spasticity
- REFERENCE :
- HEPHD2 Handbook of Experimental Pharmacology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.50- 1978- Volume(issue)/page/year: 55,527,1980 ** OTHER MULTIPLE DOSE TOXICITY DATA **
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 5760 mg/kg/22W-I
- TOXIC EFFECTS :
- Cardiac - EKG changes not diagnostic of specified effects Related to Chronic Data - death
- REFERENCE :
- ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 30,1709,1980
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 650 mg/kg/7W-I
- TOXIC EFFECTS :
- Cardiac - EKG changes not diagnostic of specified effects
- REFERENCE :
- ARTODN Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- Volume(issue)/page/year: 51,43,1982
马普替林安全信息
[ 危险品运输编码 ]:
3249
[ 包装等级 ]:
III
[ 危险类别 ]:
6.1(b)
[ 海关编码 ]:
2921499090
马普替林合成路线
马普替林上下游产品
马普替林上游产品
马普替林下游产品
马普替林制备
由β-(9-蒽基)丙酸经还原得9-(3-羟基丙基)蒽,经氯代后与甲胺缩合得β[(9-蒽基)丙基]甲胺,然后与乙烯缩合制得麦普替林。
马普替林海关
[ 海关编码 ]: 2921499090
[ 中文概述 ]:
2921499090 其他芳香单胺及衍生物及它们的盐. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:30.0%
[ 申报要素 ]: 品名, 成分含量, 用途
[ Summary ]:
2921499090 other aromatic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%
相关药品:
推荐生产厂家/供应商:
公司名:上海阿拉丁生化科技股份有限公司
区域:上海市浦东新区
价格:
¥3791.0/100mg
¥需询单/1g
¥需询单/1g
¥需询单/1g
联系人:阿拉丁李高志
产品详情:马普替林
查看所有供应商请点击:
相关化合物
【马普替林】化源网提供马普替林CAS号10262-69-8,马普替林MSDS及其说明、性质、英文名、生产厂家、作用/用途、分子量、密度、沸点、熔点、结构式等。CAS号查询马普替林上化源网,专业又轻松。>>电脑版:马普替林
标题:马普替林_用途_密度_沸点_马普替林CAS号【10262-69-8】_化源网 地址:https://m.chemsrc.com/mip/cas/10262-69-8_752273.html